Axinellin B

General Information


DRACP ID  DRACP04495

Peptide Name   Axinellin B

Sequence  LVPWPFPT

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C50H69N9O10

Absent amino acids  ACDEGHIKMNQRSY

Common amino acids  P

Mass  108118

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  1170

Hydrophobicity  55

Aliphatic Index  85

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  785.71

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Axinellins A and B: new proline-containing antiproliferative cyclopeptides from the Vanuatu sponge Axinella carteri

Doi Not available

Year  1998

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20093

DRACP is developed by Dr.Zheng's team.